Sign In
Buy TMO
$482.03
+8.08 (+1.70%)
At Close: Jun 04, 2026
Thermo Fisher Scientific Inc. (TMO) CEO Marc Casper on Q2 2022 Results - Earnings Call Transcript
01:05pm, Thursday, 28'th Jul 2022
Thermo Fisher Scientific Inc. (NYSE:TMO ) Q2 2022 Earnings Conference Call July 28, 2022 8:30 AM ET Company Participants Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, Pres
Thermo Fisher (TMO) Q2 Earnings Top Estimates, Margins Down
12:30pm, Thursday, 28'th Jul 2022
The year-over-year decline in Thermo Fisher's (TMO) Life Science Solutions and Specialty Diagnostics segment revenues is disappointing.
Thermo Fisher Scientific (TMO) Q2 Earnings and Revenues Top Estimates
11:25am, Thursday, 28'th Jul 2022 Zacks Investment Research
Thermo Fisher (TMO) delivered earnings and revenue surprises of 11.99% and 11.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
7 S&P 500 Stocks to Buy on the Dip
07:39am, Thursday, 28'th Jul 2022
S&P 500 stocks to buy on the dip is our topic today. Unrelenting inflation and the potential response from the Federal Reserve have been of particular concern to investors.
Medical Device Stocks to Watch for Earnings on Jul 28
04:05pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Medical Device players are likely to have benefited from the reopening of economies and several efforts to combat staffing challenges. Let's see how LH, TMO and BIO will likely fare this time.
Is a Surprise Coming for Thermo Fisher (TMO) This Earnings Season?
03:02pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Surprise Coming for Thermo Fisher (TMO) This Earnings Season?
12:25pm, Wednesday, 27'th Jul 2022
Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
3 MedTech Stocks That are Likely to Beat This Earnings Season
12:23pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how STE, TMO and IDXX are poised ahead of their earnings releases.
Idexx Laboratories (IDXX) Expected to Beat Earnings Estimates: Should You Buy?
02:01pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Thermo Fisher: Life Science Juggernaut On The Path To $1 Trillion In Market Cap
01:17pm, Tuesday, 26'th Jul 2022
Thermo Fisher Scientific is an under-the-radar healthcare company that prints money. What does Thermo Fisher do? Science! Some examples – manufacturing of lab equipment, diagnostic tests, and vaccin
Thermo Fisher: Why Buying Its 0.2% Yield Makes Sense
12:33am, Sunday, 24'th Jul 2022
Thermo Fisher is the perfect dividend growth stock despite its 0.20% dividend yield, which seems like a dealbreaker. However, it has all characteristics to deliver outperforming long-term capital gain
Can Thermo Fisher (TMO) Keep the Earnings Surprise Streak Alive?
04:10pm, Thursday, 21'st Jul 2022 Zacks Investment Research
Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Thermo Fisher Scientific (TMO) Gains But Lags Market: What You Should Know
10:00pm, Wednesday, 20'th Jul 2022 Zacks Investment Research
Thermo Fisher Scientific (TMO) closed the most recent trading day at $538.65, moving +0.33% from the previous trading session.
What's in Store for Thermo Fisher (TMO) in Q2 Earnings?
02:18pm, Monday, 18'th Jul 2022 Zacks Investment Research
The emergence of the new virus variants, through the months of Q2, is likely to have led to top-line contributions within Thermo Fisher's (TMO) Life-Science Solutions segment.
The Zacks Analyst Blog Highlights Eli Lilly, Thermo Fisher Scientific, TotalEnergies, Amgen and Marathon Petroleum
12:15pm, Monday, 18'th Jul 2022 Zacks Investment Research
Eli Lilly, Thermo Fisher Scientific, TotalEnergies, Amgen and Marathon Petroleum have been included in this Analyst Blog.
